About Advanced Enzyme Technologies Limited
Data last updated: 05 January 2026
Advanced Enzyme Technologies Limited is a public limited company based in Thane, Maharashtra, India. It specialises in industrial enzymes and biochemicals, a part of the broader chemicals and materials sector. Incorporated on 15 March 1989, the company has been in operation for over 37 years.
Registered with ROC Mumbai under CIN L24200MH1989PLC051018. Listed on BSE: 540025 and NSE: ADVENZYMES.
Capital: an authorised share capital of ₹35 Cr and a paid-up capital of ₹22.39 Cr. Formerly known as Advanced Biochemicals Private Limited and Advanced Biochemicals Limited. It is led by directors including Vandana Ravindra Tilak and Beni Prasad Rauka.
Last AGM: 30 July 2025. Financial statements filed for year ended 31 March 2025. Office: Sun Magnectica 5Th Floor Near Lic Service Road Louis Wadi, Thane, Maharashtra, India – 400604.
As per the financials filed for FY 2025, the company reported a revenue of ₹669.95 Cr, a growth of 1% compared to the previous year.
The company has a workforce of approximately 462 employees as per the latest available data. Its group structure includes 3 subsidiaries.
The company is associated with 1 brand - Advanced Enzyme Technologies. As per MCA filings, the company has open charges of ₹30 Cr and satisfied charges of ₹218.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website advancedenzymes.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressSun Magnectica 5Th Floor Near Lic Service Road Louis Wadi, Thane, Maharashtra, India – 400604
-
IndustryChemicals and Materials, Industrial Enzymes & Biochemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited has undergone 2 name changes throughout its history. The company was previously known as Advanced Biochemicals Private Limited, and Advanced Biochemicals Limited. The current legal name is Advanced Enzyme Technologies Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Advanced Enzyme Technologies Limited | Current |
| Advanced Biochemicals Private Limited | Previous |
| Advanced Biochemicals Limited | Previous |
CIN History of Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited has one previous CIN (Corporate Identification Number): U24200MH1989PLC051018. The current CIN is L24200MH1989PLC051018, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24200MH1989PLC051018 | Current |
| U24200MH1989PLC051018 | Previous |
Associated Brands with Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited operates one associated brand: Advanced Enzyme Technologies. These brands represent Advanced Enzyme Technologies Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Enzymes are manufactured for nutrition, food, feed, and textile industries. | advancedenzymes.com |
Competitors & Alternatives of Advanced Enzyme Technologies Limited
Brands and companies operating in the same space as Advanced Enzyme Technologies Limited include Zivo Bioscience, Enzymotec, The DuPont Nutrition and Health and 4 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Zivo Bioscience
|
Bioactive compounds from algal strain | Keego Harbor, United States, United States | 1983 |
Enzymotec
|
Bio-functional lipid ingredients are developed for nutritional and pharmaceutical uses. | Kfar Saba, Israel, Israel | 1998 |
The DuPont Nutrition and Health
|
Manufactures a range of health ingredients | Copenhagen, Denmark, Denmark | 1989 |
Kaffe Bueno
|
Coffee beans are supplied by Kaffe Bueno in multiple categories. | Copenhagen, Denmark, Denmark | 2016 |
Zarbees
|
Natural cough remedies and wellness products are developed by Zarbees. | Draper, United States, United States | 2008 |
TerraVia
|
Algae-based specialty ingredients are manufactured and supplied for food applications. | San Francisco, United States, United States | 2003 |
Noblegen
|
Naturally-derived ingredients from microorganisms are developed for human nutrition. | Peterborough, Canada, Canada | 2013 |
Business Activity of Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited is audited by M S K A and Associates LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| M S K A and Associates LLP (ICAI peer reviewed, certificate valid till 2027-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited is currently managed by 11 directors, with 21 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vandana Ravindra Tilak | Director | 01 Jul 2023 | 3 Years 0 Months | Current |
|
Beni Prasad Rauka
Also directs:
Saiganesh Enzytech Solutions Private Limited, Advanced Bio-Agro Tech Limited, Advanced Enzytech Solutions Limited and 4 more
|
Cfo | 26 May 2015 | 11 Years 1 Months | Current |
| Rajshree Patel | Director | 12 Jun 2020 | 6 Years 0 Months | Current |
|
Nitin Jagannath Deshmukh
Also directs:
Bioneeds India Private Limited, Samta Mines And Minerals Limited, Biorad Medisys Private Limited and 1 more
|
Director | 01 Jul 2022 | 4 Years 0 Months | Current |
| Vinodkumar Jajoo Hiralal | Director | 09 Feb 2019 | 7 Years 5 Months | Current |
|
Sunny Sharma
Also directs:
Marksans Pharma Limited, Arcatron Mobility Private Limited, Lattice Medtech Private Limited and 5 more
|
Director | 02 Nov 2019 | 6 Years 8 Months | Current |
Financials of Advanced Enzyme Technologies Limited FY 2026 filings available
Advanced Enzyme Technologies Limited reported revenue of ₹745.76 Cr (up 17.09% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹745.76 Cr | ₹636.91 Cr | ₹623.87 Cr | ₹540.64 Cr | ₹529.38 Cr | ₹501.84 Cr | ₹443.99 Cr |
| Other Income | ₹34.83 Cr | ₹33.04 Cr | ₹36.66 Cr | ₹25.46 Cr | ₹6.42 Cr | ₹8.85 Cr | ₹5.64 Cr |
| Total Income | ₹780.59 Cr | ₹669.95 Cr | ₹660.53 Cr | ₹566.09 Cr | ₹535.8 Cr | ₹510.69 Cr | ₹449.63 Cr |
| Cost of Materials Consumed | ₹194.31 Cr | ₹161.96 Cr | ₹155.45 Cr | ₹127.51 Cr | ₹130.26 Cr | ₹100.18 Cr | ₹90.6 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹2 Lakh | ₹1.7 Lakh | ₹6.6 Lakh | ₹2.8 Lakh | ₹23 Lakh |
| Changes in Inventories | -₹1.36 Cr | -₹10.1 Cr | -₹10.89 Cr | ₹4.28 Cr | -₹20.61 Cr | -₹1.16 Cr | -₹9.92 Cr |
| Employee Benefit Expense | ₹162.29 Cr | ₹141.54 Cr | ₹128.37 Cr | ₹114.8 Cr | ₹103.96 Cr | ₹87.11 Cr | ₹80.19 Cr |
| Finance Costs | ₹2.63 Cr | ₹3.56 Cr | ₹2.93 Cr | ₹2.42 Cr | ₹1.8 Cr | ₹1.59 Cr | ₹3.04 Cr |
| Depreciation & Amortisation | ₹40.09 Cr | ₹36.56 Cr | ₹35.24 Cr | ₹35.03 Cr | ₹34.98 Cr | ₹28.41 Cr | ₹25.78 Cr |
| Other Expenses | ₹161.45 Cr | ₹149.07 Cr | ₹146.46 Cr | ₹137.59 Cr | ₹114.29 Cr | ₹84.16 Cr | ₹80.56 Cr |
| Total Expenses | ₹559.41 Cr | ₹482.59 Cr | ₹457.58 Cr | ₹421.64 Cr | ₹364.75 Cr | ₹300.32 Cr | ₹270.47 Cr |
| Profit Before Exceptional Items & Tax | ₹221.18 Cr | ₹187.36 Cr | ₹202.95 Cr | ₹144.45 Cr | ₹171.06 Cr | ₹210.37 Cr | ₹179.16 Cr |
| Exceptional Items | ₹11.36 Cr | ₹0 | -₹15.13 Cr | -₹4.06 Cr | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹232.54 Cr | ₹187.36 Cr | ₹187.82 Cr | ₹140.39 Cr | ₹171.06 Cr | ₹210.37 Cr | ₹179.16 Cr |
| Total Tax Expense | ₹58.93 Cr | ₹53.39 Cr | ₹50.87 Cr | ₹36.52 Cr | ₹47.26 Cr | ₹58.91 Cr | ₹46.11 Cr |
| Net Profit | ₹173.61 Cr | ₹133.97 Cr | ₹136.95 Cr | ₹103.87 Cr | ₹123.8 Cr | ₹151.46 Cr | ₹133.05 Cr |
| attributable to Owners | ₹168.72 Cr | ₹131.12 Cr | ₹133.31 Cr | ₹105.64 Cr | ₹119.58 Cr | ₹146.2 Cr | ₹129.29 Cr |
| attributable to NCI | ₹4.89 Cr | ₹2.86 Cr | ₹3.65 Cr | -₹1.77 Cr | ₹4.22 Cr | ₹5.27 Cr | ₹3.76 Cr |
| Other Comprehensive Income | ₹94.81 Cr | ₹18.82 Cr | ₹9.25 Cr | ₹54.63 Cr | ₹16.52 Cr | -₹9.93 Cr | ₹39.48 Cr |
| Total Comprehensive Income | ₹268.42 Cr | ₹152.8 Cr | ₹146.2 Cr | ₹158.5 Cr | ₹140.32 Cr | ₹141.53 Cr | ₹172.53 Cr |
| EBITDA (computed) | ₹263.9 Cr | ₹227.48 Cr | ₹241.12 Cr | ₹181.9 Cr | ₹207.84 Cr | ₹240.38 Cr | ₹207.97 Cr |
| Basic EPS | ₹15.08 | ₹11.72 | ₹11.92 | ₹9.45 | ₹10.70 | ₹13.09 | ₹11.58 |
| Diluted EPS | ₹15.06 | ₹11.71 | ₹11.92 | ₹9.45 | ₹10.68 | ₹13.07 | ₹11.56 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹1,838.76 Cr | ₹1,621.35 Cr | ₹1,535.46 Cr | ₹1,421.85 Cr |
| Non-current Assets | ₹795.19 Cr | ₹741.48 Cr | ₹725.72 Cr | ₹699.74 Cr |
| Current Assets | ₹1,043.57 Cr | ₹879.87 Cr | ₹809.74 Cr | ₹722.11 Cr |
| Property, Plant & Equipment | ₹275.83 Cr | ₹292.94 Cr | ₹276.53 Cr | ₹273.21 Cr |
| Inventories | ₹177.28 Cr | ₹157.31 Cr | ₹148.46 Cr | ₹123.99 Cr |
| Trade Receivables | ₹145.02 Cr | ₹115.4 Cr | ₹98.57 Cr | ₹100.34 Cr |
| Cash & Equivalents | ₹108.76 Cr | ₹94.23 Cr | ₹113.75 Cr | ₹96.42 Cr |
| Equity (Net Worth) | ₹1,683.12 Cr | ₹1,468.67 Cr | ₹1,371.08 Cr | ₹1,284.17 Cr |
| Equity Share Capital | ₹22.39 Cr | ₹22.38 Cr | ₹22.37 Cr | ₹22.37 Cr |
| Borrowings (Non-current) | ₹7.89 Cr | ₹9.18 Cr | ₹6.96 Cr | ₹7.8 Cr |
| Borrowings (Current) | ₹12.64 Cr | ₹12.35 Cr | ₹18.15 Cr | ₹5.44 Cr |
| Total Debt (computed) | ₹20.53 Cr | ₹21.54 Cr | ₹25.11 Cr | ₹13.24 Cr |
| Current Liabilities | ₹106.72 Cr | ₹96.76 Cr | ₹106.36 Cr | ₹77.57 Cr |
| Total Liabilities | ₹155.64 Cr | ₹152.68 Cr | ₹164.38 Cr | ₹137.68 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹156.78 Cr | ₹142.5 Cr | ₹141.37 Cr | ₹140.36 Cr | ₹123.52 Cr |
| Investing Cash Flow | -₹74.13 Cr | -₹89.1 Cr | -₹64.65 Cr | -₹298.18 Cr | -₹26.14 Cr |
| Financing Cash Flow | -₹70.37 Cr | -₹72.54 Cr | -₹59.24 Cr | -₹25.8 Cr | -₹27.38 Cr |
| Capital Expenditure | ₹52.23 Cr | ₹33.81 Cr | ₹42.31 Cr | ₹38.11 Cr | ₹28.12 Cr |
| Free Cash Flow (computed) | ₹104.55 Cr | ₹108.69 Cr | ₹99.06 Cr | ₹102.26 Cr | ₹95.4 Cr |
| Dividends Paid | ₹59.78 Cr | ₹59.03 Cr | ₹56.71 Cr | ₹12.54 Cr | ₹0 |
| Net Change in Cash | ₹14.53 Cr | -₹19.53 Cr | ₹17.33 Cr | -₹170.96 Cr | ₹75.44 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹203.37 Cr | ₹171.95 Cr | ₹184.53 Cr | ₹185.91 Cr | ₹167.18 Cr | ₹169.11 Cr | ₹146.1 Cr | ₹154.52 Cr | ₹157.82 Cr | ₹160.94 Cr | ₹157.84 Cr | ₹147.28 Cr |
| Other Income | ₹7.23 Cr | ₹8.47 Cr | ₹10.28 Cr | ₹8.85 Cr | ₹8.75 Cr | ₹7.69 Cr | ₹9.62 Cr | ₹6.99 Cr | ₹9.5 Cr | ₹14.4 Cr | ₹6.09 Cr | ₹6.67 Cr |
| Total Income | ₹210.6 Cr | ₹180.42 Cr | ₹194.81 Cr | ₹194.76 Cr | ₹175.92 Cr | ₹176.8 Cr | ₹155.71 Cr | ₹161.52 Cr | ₹167.31 Cr | ₹175.33 Cr | ₹163.94 Cr | ₹153.95 Cr |
| Cost of Materials Consumed | ₹55.96 Cr | ₹45.64 Cr | ₹48.74 Cr | ₹43.97 Cr | ₹45.94 Cr | ₹36.76 Cr | ₹39.05 Cr | ₹40.2 Cr | ₹35.9 Cr | ₹44 Cr | ₹29.87 Cr | ₹45.68 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹2.04 Lakh | ₹0 |
| Changes in Inventories | ₹96.9 Lakh | -₹4.23 Cr | -₹4.18 Cr | ₹6.08 Cr | ₹14.5 Lakh | ₹2.07 Cr | -₹6.36 Cr | -₹5.95 Cr | -₹38.1 Lakh | -₹8.94 Cr | ₹7.11 Cr | -₹8.69 Cr |
| Employee Benefit Expense | ₹41.94 Cr | ₹41.26 Cr | ₹39.37 Cr | ₹39.71 Cr | ₹36.84 Cr | ₹34.52 Cr | ₹35.52 Cr | ₹34.66 Cr | ₹32.48 Cr | ₹32.13 Cr | ₹31.68 Cr | ₹32.08 Cr |
| Finance Costs | ₹57.3 Lakh | ₹56.8 Lakh | ₹72.2 Lakh | ₹76.4 Lakh | ₹81.1 Lakh | ₹94.3 Lakh | ₹92.9 Lakh | ₹87.4 Lakh | ₹84.9 Lakh | ₹67.6 Lakh | ₹75.32 Lakh | ₹64.9 Lakh |
| Depreciation & Amortisation | ₹10.19 Cr | ₹10.21 Cr | ₹10.08 Cr | ₹9.62 Cr | ₹10.08 Cr | ₹8.97 Cr | ₹8.9 Cr | ₹8.61 Cr | ₹9.28 Cr | ₹8.6 Cr | ₹8.73 Cr | ₹8.63 Cr |
| Other Expenses | ₹41.27 Cr | ₹39.93 Cr | ₹40.53 Cr | ₹39.72 Cr | ₹38.65 Cr | ₹40.5 Cr | ₹35.46 Cr | ₹34.45 Cr | ₹34.45 Cr | ₹39.99 Cr | ₹37.84 Cr | ₹34.18 Cr |
| Total Expenses | ₹150.9 Cr | ₹133.37 Cr | ₹135.27 Cr | ₹139.86 Cr | ₹132.46 Cr | ₹123.78 Cr | ₹113.5 Cr | ₹112.84 Cr | ₹112.57 Cr | ₹116.45 Cr | ₹116.01 Cr | ₹112.54 Cr |
| Profit Before Exceptional Items & Tax | ₹59.69 Cr | ₹47.05 Cr | ₹59.54 Cr | ₹54.9 Cr | ₹43.46 Cr | ₹53.02 Cr | ₹42.21 Cr | ₹48.67 Cr | ₹54.74 Cr | ₹58.88 Cr | ₹47.93 Cr | ₹41.41 Cr |
| Exceptional Items | ₹11.3 Lakh | ₹11.25 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹15.13 Cr | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹59.8 Cr | ₹58.29 Cr | ₹59.54 Cr | ₹54.9 Cr | ₹43.46 Cr | ₹53.02 Cr | ₹42.21 Cr | ₹48.67 Cr | ₹39.61 Cr | ₹58.88 Cr | ₹47.93 Cr | ₹41.41 Cr |
| Total Tax Expense | ₹14.55 Cr | ₹15.11 Cr | ₹14.81 Cr | ₹14.46 Cr | ₹16.73 Cr | ₹14.15 Cr | ₹8.82 Cr | ₹13.7 Cr | ₹9.74 Cr | ₹16.38 Cr | ₹12.73 Cr | ₹12.03 Cr |
| Net Profit | ₹45.25 Cr | ₹43.18 Cr | ₹44.73 Cr | ₹40.44 Cr | ₹26.73 Cr | ₹38.88 Cr | ₹33.39 Cr | ₹34.98 Cr | ₹29.87 Cr | ₹42.5 Cr | ₹35.2 Cr | ₹29.38 Cr |
| attributable to Owners | ₹42.96 Cr | ₹42.5 Cr | ₹43.33 Cr | ₹39.93 Cr | ₹26.48 Cr | ₹37.65 Cr | ₹32.83 Cr | ₹34.15 Cr | ₹28.31 Cr | ₹41.77 Cr | ₹34.41 Cr | ₹28.81 Cr |
| attributable to NCI | ₹2.29 Cr | ₹68.3 Lakh | ₹1.41 Cr | ₹51 Lakh | ₹24.6 Lakh | ₹1.23 Cr | ₹56 Lakh | ₹82.4 Lakh | ₹1.56 Cr | ₹72.8 Lakh | ₹78.79 Lakh | ₹56.9 Lakh |
| Other Comprehensive Income | ₹47.93 Cr | ₹11.9 Cr | ₹31.21 Cr | ₹3.77 Cr | ₹65.9 Lakh | ₹13.08 Cr | ₹4.9 Cr | ₹18.6 Lakh | ₹1.05 Cr | ₹2.94 Cr | ₹7.3 Cr | -₹2.04 Cr |
| Total Comprehensive Income | ₹93.19 Cr | ₹55.08 Cr | ₹75.94 Cr | ₹44.21 Cr | ₹27.39 Cr | ₹51.95 Cr | ₹38.29 Cr | ₹35.16 Cr | ₹30.92 Cr | ₹45.45 Cr | ₹42.5 Cr | ₹27.34 Cr |
| EBITDA (computed) | ₹70.46 Cr | ₹57.82 Cr | ₹70.34 Cr | ₹65.28 Cr | ₹54.35 Cr | ₹62.94 Cr | ₹52.03 Cr | ₹58.16 Cr | ₹64.87 Cr | ₹68.16 Cr | ₹57.41 Cr | ₹50.69 Cr |
| Basic EPS | ₹3.84 | ₹3.80 | ₹3.87 | ₹3.57 | ₹2.37 | ₹3.36 | ₹2.94 | ₹3.05 | ₹2.53 | ₹3.74 | ₹3.08 | ₹2.58 |
| Diluted EPS | ₹3.84 | ₹3.79 | ₹3.87 | ₹3.57 | ₹2.37 | ₹3.36 | ₹2.93 | ₹3.05 | ₹2.53 | ₹3.74 | ₹3.08 | ₹2.58 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹452.77 Cr | ₹351.41 Cr | ₹365.47 Cr | ₹311.53 Cr | ₹272.8 Cr | ₹283.47 Cr | ₹247.35 Cr |
| Other Income | ₹63.39 Cr | ₹61.49 Cr | ₹58.81 Cr | ₹9.81 Cr | ₹9.08 Cr | ₹6.82 Cr | ₹9 Cr |
| Total Income | ₹516.15 Cr | ₹412.9 Cr | ₹424.28 Cr | ₹321.34 Cr | ₹281.88 Cr | ₹290.3 Cr | ₹256.36 Cr |
| Cost of Materials Consumed | ₹187.72 Cr | ₹148.8 Cr | ₹139.56 Cr | ₹121.43 Cr | ₹112.72 Cr | ₹95.03 Cr | ₹94.44 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹3.08 Cr | -₹6.47 Cr | -₹7.83 Cr | ₹1.48 Cr | -₹13.52 Cr | ₹1.27 Cr | -₹5.68 Cr |
| Employee Benefit Expense | ₹64.73 Cr | ₹56.04 Cr | ₹49.97 Cr | ₹41.42 Cr | ₹39.32 Cr | ₹34.23 Cr | ₹32.61 Cr |
| Finance Costs | ₹20.7 Lakh | ₹23.6 Lakh | ₹15.7 Lakh | ₹13.5 Lakh | ₹9.5 Lakh | ₹8.4 Lakh | ₹1.1 Cr |
| Depreciation & Amortisation | ₹12.08 Cr | ₹11.41 Cr | ₹10.9 Cr | ₹10.28 Cr | ₹9.56 Cr | ₹8.93 Cr | ₹8.81 Cr |
| Other Expenses | ₹92.97 Cr | ₹82.36 Cr | ₹78.59 Cr | ₹72.32 Cr | ₹61.63 Cr | ₹52.31 Cr | ₹49.22 Cr |
| Total Expenses | ₹354.62 Cr | ₹292.37 Cr | ₹271.34 Cr | ₹247.06 Cr | ₹209.81 Cr | ₹191.87 Cr | ₹180.5 Cr |
| Profit Before Exceptional Items & Tax | ₹161.53 Cr | ₹120.53 Cr | ₹152.94 Cr | ₹74.28 Cr | ₹72.07 Cr | ₹98.43 Cr | ₹75.85 Cr |
| Exceptional Items | -₹3.86 Cr | ₹0 | -₹18.95 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹157.67 Cr | ₹120.53 Cr | ₹133.99 Cr | ₹74.28 Cr | ₹72.07 Cr | ₹98.43 Cr | ₹75.85 Cr |
| Total Tax Expense | ₹25.87 Cr | ₹18.11 Cr | ₹25.87 Cr | ₹18.75 Cr | ₹17.56 Cr | ₹27.42 Cr | ₹17.9 Cr |
| Net Profit | ₹131.81 Cr | ₹102.42 Cr | ₹108.12 Cr | ₹55.53 Cr | ₹54.51 Cr | ₹71.01 Cr | ₹57.96 Cr |
| Other Comprehensive Income | ₹84.3 Lakh | -₹34.4 Lakh | -₹10.3 Lakh | ₹49.3 Lakh | ₹2.1 Lakh | -₹2.9 Lakh | -₹31.8 Lakh |
| Total Comprehensive Income | ₹132.65 Cr | ₹102.08 Cr | ₹108.02 Cr | ₹56.02 Cr | ₹54.53 Cr | ₹70.98 Cr | ₹57.64 Cr |
| EBITDA (computed) | ₹173.82 Cr | ₹132.17 Cr | ₹164 Cr | ₹84.7 Cr | ₹81.73 Cr | ₹107.44 Cr | ₹85.77 Cr |
| Basic EPS | ₹11.78 | ₹9.16 | ₹9.67 | ₹4.97 | ₹4.88 | ₹6.36 | ₹5.19 |
| Diluted EPS | ₹11.76 | ₹9.15 | ₹9.66 | ₹4.97 | ₹4.87 | ₹6.35 | ₹5.18 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹803.64 Cr | ₹688.63 Cr | ₹632.93 Cr | ₹575.8 Cr |
| Non-current Assets | ₹487.66 Cr | ₹456.43 Cr | ₹384.59 Cr | ₹386.66 Cr |
| Current Assets | ₹315.98 Cr | ₹232.2 Cr | ₹248.34 Cr | ₹189.14 Cr |
| Property, Plant & Equipment | ₹145.47 Cr | ₹150.88 Cr | ₹141.82 Cr | ₹142.45 Cr |
| Inventories | ₹116.52 Cr | ₹101.45 Cr | ₹96.88 Cr | ₹76.79 Cr |
| Trade Receivables | ₹94.32 Cr | ₹78.17 Cr | ₹75.17 Cr | ₹66.67 Cr |
| Cash & Equivalents | ₹1.89 Cr | ₹5.6 Cr | ₹1.5 Cr | ₹9.45 Cr |
| Equity (Net Worth) | ₹709.62 Cr | ₹629.34 Cr | ₹580.47 Cr | ₹525.33 Cr |
| Equity Share Capital | ₹22.39 Cr | ₹22.38 Cr | ₹22.37 Cr | ₹22.37 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹70,000 |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹70,000 |
| Current Liabilities | ₹77.84 Cr | ₹44.7 Cr | ₹40.01 Cr | ₹36.9 Cr |
| Total Liabilities | ₹94.01 Cr | ₹59.29 Cr | ₹52.46 Cr | ₹50.47 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹88.73 Cr | ₹63.48 Cr | ₹55.81 Cr | ₹50.3 Cr | ₹37.15 Cr |
| Investing Cash Flow | -₹34.19 Cr | -₹1.74 Cr | -₹6.88 Cr | -₹42.35 Cr | -₹14.28 Cr |
| Financing Cash Flow | -₹58.25 Cr | -₹57.63 Cr | -₹56.88 Cr | -₹11.99 Cr | -₹10.87 Cr |
| Capital Expenditure | ₹44.25 Cr | ₹22.34 Cr | ₹0 | ₹23.42 Cr | ₹10.54 Cr |
| Free Cash Flow (computed) | ₹44.49 Cr | ₹41.14 Cr | ₹55.81 Cr | ₹26.87 Cr | ₹26.61 Cr |
| Dividends Paid | ₹58.18 Cr | ₹57.03 Cr | ₹55.91 Cr | ₹11.18 Cr | ₹10.06 Cr |
| Net Change in Cash | -₹3.71 Cr | ₹4.11 Cr | -₹7.95 Cr | -₹4.05 Cr | ₹11.99 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹116.41 Cr | ₹95.58 Cr | ₹115.75 Cr | ₹125.02 Cr | ₹87.21 Cr | ₹100.87 Cr | ₹77.38 Cr | ₹85.96 Cr | ₹92.4 Cr | ₹91.14 Cr | ₹96.58 Cr | ₹85.35 Cr |
| Other Income | ₹5.16 Cr | ₹1.29 Cr | ₹3.08 Cr | ₹53.85 Cr | ₹4.53 Cr | ₹1.43 Cr | ₹1.66 Cr | ₹53.88 Cr | ₹3.21 Cr | ₹3.57 Cr | ₹78.5 Lakh | ₹51.25 Cr |
| Total Income | ₹121.57 Cr | ₹96.88 Cr | ₹118.83 Cr | ₹178.88 Cr | ₹91.74 Cr | ₹102.3 Cr | ₹79.03 Cr | ₹139.83 Cr | ₹95.61 Cr | ₹94.71 Cr | ₹97.36 Cr | ₹136.6 Cr |
| Cost of Materials Consumed | ₹50.14 Cr | ₹37.36 Cr | ₹48.32 Cr | ₹51.9 Cr | ₹37.79 Cr | ₹36.26 Cr | ₹37.17 Cr | ₹37.58 Cr | ₹33.45 Cr | ₹38.16 Cr | ₹32.67 Cr | ₹35.29 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹1.53 Cr | -₹3.64 Cr | -₹2.27 Cr | ₹4.36 Cr | ₹39.9 Lakh | ₹7.35 Cr | -₹8.06 Cr | -₹6.16 Cr | -₹1.95 Cr | -₹4.58 Cr | ₹4.78 Cr | -₹6.09 Cr |
| Employee Benefit Expense | ₹16.36 Cr | ₹16.1 Cr | ₹16.06 Cr | ₹16.21 Cr | ₹14.56 Cr | ₹13.34 Cr | ₹13.95 Cr | ₹14.19 Cr | ₹12.93 Cr | ₹12.68 Cr | ₹12.34 Cr | ₹12.02 Cr |
| Finance Costs | ₹6 Lakh | ₹4.5 Lakh | ₹4.9 Lakh | ₹5.3 Lakh | ₹7.7 Lakh | ₹6.1 Lakh | ₹7.6 Lakh | ₹2.2 Lakh | ₹4.8 Lakh | ₹4.1 Lakh | ₹3.3 Lakh | ₹3.5 Lakh |
| Depreciation & Amortisation | ₹3.12 Cr | ₹3.04 Cr | ₹3 Cr | ₹2.93 Cr | ₹3.11 Cr | ₹2.89 Cr | ₹2.78 Cr | ₹2.62 Cr | ₹3.07 Cr | ₹2.72 Cr | ₹2.61 Cr | ₹2.51 Cr |
| Other Expenses | ₹24.59 Cr | ₹22.3 Cr | ₹24.04 Cr | ₹22.04 Cr | ₹20.29 Cr | ₹21.86 Cr | ₹20.8 Cr | ₹19.42 Cr | ₹18.73 Cr | ₹20.33 Cr | ₹20.17 Cr | ₹19.35 Cr |
| Total Expenses | ₹92.73 Cr | ₹75.2 Cr | ₹89.21 Cr | ₹97.48 Cr | ₹76.23 Cr | ₹81.76 Cr | ₹66.71 Cr | ₹67.68 Cr | ₹66.27 Cr | ₹69.35 Cr | ₹72.6 Cr | ₹63.11 Cr |
| Profit Before Exceptional Items & Tax | ₹28.84 Cr | ₹21.67 Cr | ₹29.62 Cr | ₹81.4 Cr | ₹15.51 Cr | ₹20.54 Cr | ₹12.32 Cr | ₹72.16 Cr | ₹29.34 Cr | ₹25.36 Cr | ₹24.76 Cr | ₹73.48 Cr |
| Exceptional Items | ₹0 | -₹3.86 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹18.95 Cr | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹28.84 Cr | ₹17.82 Cr | ₹29.62 Cr | ₹81.4 Cr | ₹15.51 Cr | ₹20.54 Cr | ₹12.32 Cr | ₹72.16 Cr | ₹10.39 Cr | ₹25.36 Cr | ₹24.76 Cr | ₹73.48 Cr |
| Total Tax Expense | ₹6.55 Cr | ₹4.57 Cr | ₹7.34 Cr | ₹7.42 Cr | ₹4.46 Cr | ₹5.36 Cr | ₹3.2 Cr | ₹5.1 Cr | ₹7.25 Cr | ₹6.24 Cr | ₹6.38 Cr | ₹6 Cr |
| Net Profit | ₹22.3 Cr | ₹13.25 Cr | ₹22.28 Cr | ₹73.98 Cr | ₹11.05 Cr | ₹15.18 Cr | ₹9.13 Cr | ₹67.06 Cr | ₹3.14 Cr | ₹19.12 Cr | ₹18.38 Cr | ₹67.49 Cr |
| Other Comprehensive Income | ₹45.2 Lakh | ₹39.1 Lakh | ₹0 | ₹0 | -₹34.4 Lakh | ₹0 | ₹0 | ₹0 | -₹10.3 Lakh | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | ₹22.75 Cr | ₹13.64 Cr | ₹22.28 Cr | ₹73.98 Cr | ₹10.71 Cr | ₹15.18 Cr | ₹9.13 Cr | ₹67.06 Cr | ₹3.04 Cr | ₹19.12 Cr | ₹18.38 Cr | ₹67.49 Cr |
| EBITDA (computed) | ₹32.02 Cr | ₹24.76 Cr | ₹32.67 Cr | ₹84.38 Cr | ₹18.7 Cr | ₹23.49 Cr | ₹15.18 Cr | ₹74.8 Cr | ₹32.45 Cr | ₹28.11 Cr | ₹27.4 Cr | ₹76.03 Cr |
| Basic EPS | ₹1.99 | ₹1.18 | ₹1.99 | ₹6.61 | ₹0.99 | ₹1.36 | ₹0.82 | ₹6.00 | ₹0.28 | ₹1.71 | ₹1.64 | ₹6.04 |
| Diluted EPS | ₹1.99 | ₹1.18 | ₹1.99 | ₹6.61 | ₹0.99 | ₹1.35 | ₹0.81 | ₹5.99 | ₹0.28 | ₹1.71 | ₹1.64 | ₹6.04 |
Shareholding Pattern of Advanced Enzyme Technologies Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 43.26%, foreign institutional investors hold 25.49%, domestic institutional investors hold 5.41%, retail and other public shareholders hold 25.84% of Advanced Enzyme Technologies Limited. The company had 66,193 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 43.26% | 43.04% | 43.07% | 43.08% | 43.08% | 42.93% |
| Public | 56.74% | 56.96% | 56.93% | 56.92% | 56.92% | 57.07% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 43.26% | 43.08% | 43.49% | 49.87% | 52.70% | 55.38% | 57.88% | 57.31% | 71.32% | 70.10% |
| Public | 56.74% | 56.92% | 56.51% | 50.13% | 47.30% | 44.62% | 42.12% | 42.69% | 28.68% | 29.90% |
| Promoter change (YoY, %pts) | +0.18 | -0.41 | -6.38 | -2.83 | -2.68 | -2.50 | +0.57 | -14.01 | +1.22 | - |
Board & Governance of Advanced Enzyme Technologies Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Advanced Enzyme Technologies Limited has 9 directors - 5 independent and 1 executive. The board is chaired by Vasant L Rathi.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Vasant L Rathi | Non-Executive - Non Independent Director · Chairperson | 1993-03-05 | 1 |
| Pramod Kasat | Non-Executive - Independent Director | 2016-12-14 | 4 |
| Mukund Madhusudan Kabra | Executive Director | 1999-09-04 | 1 |
| Rasika Rathi | Non-Executive - Non Independent Director | 2019-01-08 | 1 |
| Vinodkumar Hiralal Jajoo | Non-Executive - Independent Director | 2019-02-09 | 1 |
| Sunny Sharma | Non-Executive - Non Independent Director | 2019-11-02 | 2 |
| Rajshree Patel | Non-Executive - Independent Director | 2020-06-12 | 1 |
| Nitin Jagannath Deshmukh | Non-Executive - Independent Director | 2022-07-01 | 1 |
| Vandana R Tilak | Non-Executive - Independent Director | 2023-07-01 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Vinodkumar Hiralal Jajoo (Chairperson), Pramod Kasat, Vasant L Rathi, Vandana R Tilak |
| Nomination and remuneration committee | Pramod Kasat (Chairperson), Vasant L Rathi, Rajshree Patel, Nitin Jagannath Deshmukh |
| Stakeholders Relationship Committee | Vinodkumar Hiralal Jajoo (Chairperson), Mukund Madhusudan Kabra, Nitin Jagannath Deshmukh |
| Risk Management Committee | Vinodkumar Hiralal Jajoo (Chairperson), Mukund Madhusudan Kabra, Rasika Rathi, Beni Prasad Rauka, Sanjay Basantani |
| Corporate Social Responsibility Committee | Mukund Madhusudan Kabra (Chairperson), Vasant L Rathi, Rajshree Patel |
Group Structure of Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited has 3 subsidiary companies. This group structure data is as of FY 2020. The corporate group structure reflects Advanced Enzyme Technologies Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Advanced Bio-Agro Tech Limited | U24100MH2004PLC149464 | - |
| Advanced Enzytech Solutions Limited | U24200MH2008PLC186383 | - |
| Jc Biotech Private Limited | U65993TG1991PTC013624 | - |
Showing major subsidiaries. Total: 3.
Charges & Borrowings of Advanced Enzyme Technologies Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2006 | Hdfc Bank Limited | ₹15 Cr | Open |
| 22 Jun 2005 | Citi Bank N.A. | ₹15 Cr | Open |
| 29 Jun 2022 | Axis Bank Limited | ₹5 Cr | Satisfied |
| 10 Feb 2022 | Others | ₹10 Cr | Satisfied |
| 25 Mar 2017 | Hdfc Bank Limited | ₹16.8 Lakh | Satisfied |
Total charge records: 30 View all charges
Employees and EPFO Compliance at Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited has a workforce of 462 employees as of Mar 28, 2024.
Employee Count & EPFO Data of Advanced Enzyme Technologies Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Advanced Enzyme Technologies Limited
GSTIN & GST Filing Data of Advanced Enzyme Technologies Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Advanced Enzyme Technologies Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Advanced Enzyme Technologies Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Advanced Enzyme Technologies Limited
MSME Payment Delays by Advanced Enzyme Technologies Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Advanced Enzyme Technologies Limited
Subsidiaries & Group Companies of Advanced Enzyme Technologies Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Advanced Enzyme Technologies Limited with ownership details.
MCA Filings & Documents of Advanced Enzyme Technologies Limited
MCA Filings & Documents of Advanced Enzyme Technologies Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Advanced Enzyme Technologies Limited
Recent News on Advanced Enzyme Technologies Limited
Frequently Asked Questions about Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited is an active public limited company in the chemicals and materials sector based in Thane, Maharashtra, India. It was incorporated on 15 March 1989 (37+ years old) and is registered under CIN L24200MH1989PLC051018. Listed on BSE: 540025 and NSE: ADVENZYMES. The company has 462 employees.
Advanced Enzyme Technologies Limited reported revenue of ₹669.95 Cr for FY 2025 (up 1.00% YoY).
The current directors of Advanced Enzyme Technologies Limited are:
The primary industry of Advanced Enzyme Technologies Limited is chemicals and materials. The company specifically operates in industrial enzymes and biochemicals. The company is currently active in this sector.
Yes. Advanced Enzyme Technologies Limited is listed on both BSE (code: 540025) and NSE (symbol: ADVENZYMES).
Advanced Enzyme Technologies Limited can be reached at the registered office: Sun Magnectica 5Th Floor Near Lic Service Road Louis Wadi, Thane, Maharashtra, India – 400604, or through the website advancedenzymes.com.